Skip to content
healthcare.dev

Bisoprolol Fumarate and Hydrochlorothiazide

NDC 70954-412, Bisoprolol Fumarate and Hydrochlorothiazide, tablet, from ANI Pharmaceuticals, Inc..

Product NDC
70954-412
Status
Listed
Labeler
ANI Pharmaceuticals, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA215562
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70954-412 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BISOPROLOL FUMARATE2.5 mg/1
  • HYDROCHLOROTHIAZIDE6.25 mg/1

Pharmacologic classes

Adrenergic beta-Antagonists [MoA]; Increased Diuresis [PE]; Thiazide Diuretic [EPC]; Thiazides [CS]; beta-Adrenergic Blocker [EPC]

Package NDCNDC-11Package
70954-412-107095404121030 TABLET in 1 BOTTLE (70954-412-10)
70954-412-3070954041230100 TABLET in 1 BOTTLE (70954-412-30)
70954-412-4070954041240500 TABLET in 1 BOTTLE (70954-412-40)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a26bcf78-6515-4e9f-b2dc-4aaa8ec1a82c
  • NADAC price for package 70954041230

    GET /v1/drugs/nadac/70954041230

Use it

Look up 70954-412 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70954-412 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70954-412. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.